
Keywords: Aβ; amyloid beta; AD; Alzheimer's disease; ADDL; amyloid-β-derived diffusible ligand; ALS; amyotrophic lateral sclerosis; ApoE; apolipoprotein E; ART; antiretroviral therapy; BBB; blood-brain barrier; CNS; central nervous system; CSF; cerebral spina